Modification with NaF in disequilibrium of otospongiotic origin.
D007758:Ear, Inner / Q000473:pathology; D005459:Fluorides / Q000627:therapeutic use*; D006801:Humans; D007759:Labyrinth Diseases / Q000188:drug therapy* / Q000209:etiology; D010040:Otosclerosis / Q000150:complications / Q000188:drug therapy*; D012969:Sodium Fluoride / Q000627:therapeutic use*; D014717:Vertigo / Q000209:etiology
D012969:Sodium Fluoride; D005459:Fluorides